Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Defrino

Orthopaedic Surgery Palos Heights, IL Medical Doctor

NPI 1326046319 CMS profile 59420

7600 W College Dr, Palos Heights, IL 60463

Open in the dashboard

General payments

$253,499

60 records reported · program years 2019–2025

Research payments

$65,050

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Defrino of Palos Heights, IL is reported in the CMS Open Payments database as having received $253,499 across 60 general payments and $65,050 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,674 14
2025 Research $4,200 1
2024 General $854 14
2024 Research $41,100 1
2023 General $246,269 10
2022 General $1,320 7
2021 General $136 5
2021 Research $19,750 1
2020 General $990 5
2019 General $255 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Defrino
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Paul Defrino were reported at $3,674. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Paul Defrino Orthopaedic Surgery median Middle half National median
2019 $255 $644 $140–$2,844 $163
2020 $990 $312 $75–$1,860 $114
2021 $136 $520 $117–$2,495 $132
2022 $1,320 $598 $128–$2,731 $149
2023 $246,269 $461 $128–$2,264 $160
2024 $854 $497 $134–$2,475 $164
2025 $3,674 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arteriocyte Medical Systems, Inc. $249,614 4 payments
  2. Medwest Associates $1,224 2 payments
  3. Medical Device Business Services, Inc. $944 3 payments
  4. Stryker Corporation $485 13 payments
  5. DePuy Synthes Sales Inc. $389 12 payments
  6. Wright Medical Technology, Inc. $218 3 payments
  7. Paragon 28, Inc. $91 3 payments
  8. Organogenesis Inc. $89 3 payments
  9. Lightbody Medical Technologies Inc $88 3 payments
  10. Acumed LLC $75 2 payments
  11. Other $283 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $245,999 1 payment
  2. Consulting Fee $3,900 2 payments
  3. Food and Beverage $2,400 56 payments
  4. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. InFlux $3,000 1 payment
  2. TFN ADVANCED $944 3 payments
  3. VA-LCP PLATES & SCREWS $900 1 payment
  4. Magellan $616 2 payments
  5. SALVATION $179 1 payment
  6. INFINITY $171 3 payments
  7. ACTISHIELD $159 3 payments
  8. MOTOBAND $113 3 payments
  9. FIBERGRAFT Aeridyan Matrix $75 2 payments
  10. Puraply Antimicrobial $73 2 payments
  11. Other $1,190 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Tyber Medical, LLC $65,050 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

141

Median for Orthopedic Surgery: 203

Drug cost

$1,296

Median for Orthopedic Surgery: $1,433

Branded share of claims

43.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 48 $722
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 61 $446
Clindamycin Hcl Generic 13 $101
Tramadol Hcl Generic 19 $28

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 117 billing codes

Paid by Medicare

$115,462

Of which drugs: $6,059

Medicare patients

337

Average age 74

Services billed

1,482

199 women, 138 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 66%
Diabetes 33%
Ischemic heart disease 31%
Chronic kidney disease 28%
Depression 22%
Heart failure 21%
Atrial fibrillation 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 27 35 $3

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record